StockWatch
·
YASHO INDUSTRIES · Q2 FY-2027 · THE VERDICT

Growth Momentum, Earnings Headwind: The Margin Downgrade Story

Revenue surged 89.7%, but profit contracted 6.6% quarter-on-quarter and management cut EBITDA margin guidance from 24% to 20–21%. The growth is real—but the quarter revealed cost durability, not pricing power.

Q2 FY27 resultsYASHOYasho Industries Ltd03 Nov 2026 · 6 min read
Reported PAT

₹33.7 Cr

+593% YoY

QoQ PAT change

−6.6%

despite +13% revenue

Freight cost Q2

₹20 Cr

vs ₹10 Cr Q1 (doubled)

EBITDA margin guidance

20–21%

down from 24% prior

The headline number hides the real story

Yasho's Q2 delivered ₹347.7 Cr in revenue, up a legitimate 89.7% year-on-year. But the reported profit of ₹33.7 Cr fell 6.6% quarter-on-quarter, even as sales climbed 13%. The call reveals why: freight costs doubled from ₹10 Cr to ₹20 Cr, energy prices spiked ₹1.8 Cr additional, and management cannot pass through the full hit to existing fixed-contract customers. The company raised FY-2027 capex from ₹125 Cr to ₹250 Cr and disclosed a ₹150 Cr long-term MNC supply deal—genuine positive catalysts. But it also cut EBITDA margin guidance from a stated 24% aspiration to 20–21%, signalling that cost pressures are durability, not transient.

Q2 FY27 growth rates
-78.55169.28417.12664.9589.7Revenue YoY593PAT YoY-6.6PAT QoQ
Revenue and YoY PAT growth are outliers; QoQ PAT decline is the signal. The headline profit leans on a low prior-year base (Q2 FY26 PAT ₹4.86 Cr).
Management's claims vs. what holds up
  • 62% volume growth YoY, 7% QoQ — Supported by revenue bridge (89.7% YoY with ~17% pricing contribution)

  • Export revenue 70% of Q2, up from 63% FY26 — Confirmed in Q&A by management

  • Capacity utilization 66% in Q2, up from 60% Q4 FY26 — Supported; explained by product mix shift and new customer onboarding

  • Maintain 24% EBITDA margin going forward — Contradicted; management now targets 20–21%

  • Freight cost ₹20 Cr in Q2 vs ₹10 Cr Q1 — Explicitly disclosed by CFO

  • ₹150 Cr MNC supply contract (15-year agreement) — Supported; ₹120 Cr received to date, trial Q4 FY27

What changed on this call

The key pivots from prior guidance

EBITDA margin aspiration

Maintain 24%
Q2 FY27

Target 20–21%

What it means

Downgrade — cost headwinds deemed durable

FY27 capex (Pakhajan buildings)

₹125 Cr
Q2 FY27

₹250 Cr

What it means

Upgrade — customer demand validation, 15-year MNC contract

FY28 revenue guidance

>₹1,600 Cr
Q2 FY27

>₹1,600 Cr (held)

What it means

Neutral — no change from Q1; management hedged ('don't want to commit anything more')

Long-term supply contract

Not disclosed
Q2 FY27

₹150 Cr MNC order book, 15-year term

What it means

New catalyst — de-risks revenue stream, materializes capex thesis

The cost of freight increased from INR 10 crores in Q1 to INR 20 crores in Q2. Increase in gas prices in the quarter also resulted in an additional expenditure of INR 1.8 crores.
I cannot assure that we will achieve 24% or I will achieve 25%. Too difficult to say in the current situation.

The bull-bear ledger

  • Genuine volume growth momentum: 62% YoY volume gain on strong customer demand

  • Long-term contract de-risks revenue: ₹150 Cr MNC deal over 15 years; ₹120 Cr already received

  • Capex commitment signals confidence: ₹250 Cr for two Pakhajan buildings backed by customer soft-commitments

  • Pricing power demonstrated: 10–15% price realisation increase in Q2 on strong positioning

  • Export tailwind from geopolitical shift: Chinese chemical player sanctions drive localization demand

  • QoQ profit decline despite revenue growth: ₹33.7 Cr (−6.6% QoQ) signals cost not yet under control

  • EBITDA margin guidance slashed: Downgrade from 24% to 20–21% contradicts prior confidence

  • Freight cost pass-through incomplete: Fixed-contract customers cap pricing power; ₹20 Cr freight headwind unresolved

  • Utilization lag vs. growth: 66% utilization despite 40% growth target; Phase 2 ramp-up timing uncertain (50–60% Y1 from FY28)

  • Export revenue concentration: 70% of Q2 revenue; logistics delays (30–60 days vs. 25–30 day standard) material headwind

  • Customer concentration masked by NDA: Unnamed MNC is material (₹150 Cr of ₹1,600 Cr FY28 target = ~9%)

Risks, ranked by severity for a holder

What should concern an equity holder

Margin compression durability

High

Freight doubled Q-o-Q (₹10 Cr → ₹20 Cr), energy spiked ₹1.8 Cr, management cut EBITDA guidance from 24% to 20–21%. This signals cost pressures are structural (logistics delays 30–60 days persist), not transient. Fixed-contract customers prevent 100% pricing pass-through. Risk: EBITDA margin stays depressed even as volume ramps, compressing ROI on ₹250 Cr capex.

Capacity utilization lag vs. revenue growth

Medium

Q2 utilization 66% despite 40% annual revenue growth target. Product mix shift and new customer onboarding explained it, but Phase 1 building expected only 80–85% utilization by FY29 and Phase 2 at 50–60% Y1 startup. Risk: capex ROI delayed or lower-than-modelled if ramp slower. Return on ₹250 Cr spend pushed beyond FY28.

Export logistics and geopolitical volatility

Medium

70% of Q2 revenue is export-dependent. Current shipping delays 30–60 days (vs. 25–30 day normal), freight volatile. Geopolitical sanctions on Chinese players are tailwind now, but if they normalize (Chinese players re-enter), competitive pressure rises. Risk: export margins compressed or volume loss.

Customer concentration (unnamed MNC)

Medium

₹150 Cr MNC supply contract (15-year, 15% of FY28 ₹1,600 Cr target) is material, but NDA prevents disclosure of customer name or product scope. Trial Q4 FY27, launch Q1 FY28 — execution risk if trial fails. Risk: single-customer loss or ramp delay could miss FY28 guidance.

Raw material and energy price volatility

Low-Medium

10–15% raw material price increase in Q2; energy cost spiked ₹1.8 Cr. Analyst noted 'unavailability of raw material because of crisis.' Sourcing tightness may persist. Risk: if pricing power erodes further or sourcing breaks, margin outlook worsens.

How the street is positioned

Valuation and drawdown context: The stock trades at ₹3,279.5, down 34.3% from its all-time high of ₹4,990, and is trading below its 20-day (₹3,744) and 50-day (₹3,971) moving averages, though above its 200-day average (₹2,595). This suggests a correction in growth/valuation expectations post-ATH, but the stock remains up 190% off its 52-week low of ₹1,130. The drawdown reflects market skepticism on margin durability and utilization execution, not fundamentals collapse.

Institutional positioning: FII ownership stands at 5.74% (latest Q1 FY27 filing), up marginally from 5.71% in Q4 FY26. DII holdings are 2.21%, up from 1.97% Q4 FY26. Promoter stake remains steady at 67.94%. The flat-to-modest FII inflow and DII pickup suggest cautious institutional interest despite the margin headwinds; insiders are not selling. This is consistent with a 'prove-it' posture — the street wants to see margin recovery and capex ROI before recommitting.

The street's verdict: The 34% drawdown from ATH, combined with neutral-to-cautious Q&A sentiment (analysts pressed hard on utilization lag, margin guidance cut, and cost pass-through limits), signals the market has repriced growth downward. But the mild FII accumulation and stable insider holding suggest conviction remains on the long-term thesis (capex, MNC contract, export tailwind). The stock's current valuation reflects a 'show-me' moment: margin recovery and Phase 1 capex deployment will determine whether the drawdown was overblown or prescient.

The debate

What to watch next

The 2–3 concrete things that resolve the debate by Q3 FY27
  • 1 · Freight cost stabilization and logistics delays recovery

    Q2 freight doubled to ₹20 Cr; logistics delays running 30–60 days vs. 25–30 day normal. If Q3 freight returns to ₹12–₹15 Cr range and shipping normalizes to 25–30 days, margin recovery toward 22–23% is credible. If freight stays ≥₹18 Cr and delays persist, management's 20–21% aspiration becomes the ceiling, not a floor. Track CFO commentary on freight outlook in Q3 results and call.

  • 2 · MNC contract trial production milestone (target Q4 FY27)

    ₹150 Cr MNC supply deal (15-year, ₹120 Cr received to date) trial production starts Q4 FY27, commercialization Q1 FY28. If trial succeeds and Phase 1 building ramps on schedule, this is the catalyst for FY28 >₹1,600 Cr achievement. If trial slips or commercialization delays, capex payback and FY28 guidance become at-risk. Watch for management commentary on trial progress in Q3 call.

  • 3 · Phase 1 building capacity utilization trend (Q3–Q4 FY27)

    Q2 utilization 66%; target 75% by FY27 end, then 80–85% by FY29. If utilization climbs to 70%+ by Q3 and stays there through Q4, margin recovery thesis gains credibility. If utilization stalls below 68%, the 'ramp execution risk' becomes real, and Phase 2 capex ROI falls into question. Track quarterly utilization disclosures and management tone on new customer onboarding success.

The single number to track from here

Operating profit margin (OPM) in Q3 and Q4 FY27. Q2 OPM is 20.9%; management guidance is EBITDA 20–21%. If Q3 OPM stays ≥20.5%, the margin floor is holding and recovery is plausible. If Q3 OPM falls to ₹1,600 Cr revenue target translates to earnings growth or earnings stagnation.

Yasho Industries delivered genuine growth — 89.7% revenue, 62% volume gain, real customer demand, a long-term contract, and capex commitment. But the quarter also proved that cost inflation (freight, energy) is eating earnings faster than pricing can offset it. Management's EBITDA margin downgrade from 24% to 20–21% is the tell: they are not confident on recovery in the near term. The stock's 34% drawdown from ATH reflects this repricing correctly. The next leg of returns depends not on revenue growth — that's proven — but on margin recovery. If freight normalizes and Phase 1 utilization ramps, the stock could re-rate toward ₹4,000+. If costs stay elevated and utilization lags, the stock stays ranged ₹2,600–₹3,800. For a holder, the answer lies in Q3 and Q4 operating profit. For a prospective buyer, the 34% correction offers entry near fair value on a 20–21% EBITDA margin base — but not upside, until margins prove.

Informational and educational content only. Not investment advice.